GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $595,000 | -23.1% | 14,605 | -18.3% | 0.02% | -38.5% |
| Q4 2020 | $774,000 | +9.2% | 17,879 | +39.1% | 0.03% | -7.1% |
| Q3 2020 | $709,000 | -6.7% | 12,850 | +6.8% | 0.03% | -9.7% |
| Q2 2020 | $760,000 | -18.4% | 12,037 | -33.9% | 0.03% | -36.7% |
| Q1 2020 | $931,000 | -0.2% | 18,215 | +55.2% | 0.05% | +32.4% |
| Q4 2019 | $933,000 | +43.8% | 11,740 | -12.2% | 0.04% | +42.3% |
| Q3 2019 | $649,000 | -4.4% | 13,366 | +3.5% | 0.03% | 0.0% |
| Q2 2019 | $679,000 | – | 12,918 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |